Excelsior Biopharma

Excelsior Biopharma EBIT per Employee

EBIT per Employee of Excelsior Biopharma (6496.TWO) as of Oct 29, 2026.

EBIT per Employee

-TWD

Last updated:

EBIT per Employee of Excelsior Biopharma is 2026 - TWD. EBIT per Employee of Excelsior Biopharma was 2025 - TWD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Excelsior Biopharma Stock analysis

What does Excelsior Biopharma do? Excelsior Biopharma Inc., headquartered in Taipei City, Taiwan, operates in the Health Care sector. The company focuses on the research, development, manufacturing, and distribution of pharmaceutical products, including prescription and non-prescription drugs, health care products, medical equipment, and rapid test reagents. Listed on 19 December 2014, Excelsior Biopharma serves both domestic and international markets with its diverse product portfolio. Excelsior Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Excelsior Biopharma stock

On Eulerpool you can find the complete historical development of EBIT per Employee Excelsior Biopharma since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Excelsior Biopharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Excelsior Biopharma

All Key Metrics — Excelsior Biopharma